544 related articles for article (PubMed ID: 19951205)
1. Update of HPV-associated female genital cancers in the United States, 1999-2004.
Watson M; Saraiya M; Wu X
J Womens Health (Larchmt); 2009 Nov; 18(11):1731-8. PubMed ID: 19951205
[TBL] [Abstract][Full Text] [Related]
2. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
[TBL] [Abstract][Full Text] [Related]
3. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.
Jemal A; Simard EP; Dorell C; Noone AM; Markowitz LE; Kohler B; Eheman C; Saraiya M; Bandi P; Saslow D; Cronin KA; Watson M; Schiffman M; Henley SJ; Schymura MJ; Anderson RN; Yankey D; Edwards BK
J Natl Cancer Inst; 2013 Feb; 105(3):175-201. PubMed ID: 23297039
[TBL] [Abstract][Full Text] [Related]
4. Vulvar Cancer Incidence in the United States and its Relationship to Human Papillomavirus Vaccinations, 2001-2018.
Berenson AB; Chang M; Hawk ET; Ramondetta LM; Hoang T
Cancer Prev Res (Phila); 2022 Nov; 15(11):777-784. PubMed ID: 35969832
[TBL] [Abstract][Full Text] [Related]
5. Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.
Nygård M; Hansen BT; Dillner J; Munk C; Oddsson K; Tryggvadottir L; Hortlund M; Liaw KL; Dasbach EJ; Kjær SK
PLoS One; 2014; 9(2):e88323. PubMed ID: 24505474
[TBL] [Abstract][Full Text] [Related]
6. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States.
Wu X; Matanoski G; Chen VW; Saraiya M; Coughlin SS; King JB; Tao XG
Cancer; 2008 Nov; 113(10 Suppl):2873-82. PubMed ID: 18980291
[TBL] [Abstract][Full Text] [Related]
7. Incidence of in situ and invasive vulvar cancer in the US, 1998-2003.
Saraiya M; Watson M; Wu X; King JB; Chen VW; Smith JS; Giuliano AR
Cancer; 2008 Nov; 113(10 Suppl):2865-72. PubMed ID: 18980209
[TBL] [Abstract][Full Text] [Related]
8. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
Chaturvedi AK
J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
[TBL] [Abstract][Full Text] [Related]
9. Cancers attributable to human papillomavirus infection.
Grulich AE; Jin F; Conway EL; Stein AN; Hocking J
Sex Health; 2010 Sep; 7(3):244-52. PubMed ID: 20719211
[TBL] [Abstract][Full Text] [Related]
10. Distribution of treatment for human papillomavirus-associated gynecologic carcinomas before prophylactic vaccine.
Negoita S; Harrison JN; Qiao B; Ekwueme DU; Flowers LC; Kahn AR
Cancer; 2008 Nov; 113(10 Suppl):2926-35. PubMed ID: 18980276
[TBL] [Abstract][Full Text] [Related]
11. Geographic and temporal variations in the incidence of vulvar and vaginal cancers.
Bray F; Laversanne M; Weiderpass E; Arbyn M
Int J Cancer; 2020 Nov; 147(10):2764-2771. PubMed ID: 32410226
[TBL] [Abstract][Full Text] [Related]
12. Global burden of human papillomavirus and related diseases.
Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus-associated cancers - United States, 2004-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Apr; 61():258-61. PubMed ID: 22513527
[TBL] [Abstract][Full Text] [Related]
14. Incidence of potentially human papillomavirus-related neoplasms in the United States, 1978 to 2007.
Kurdgelashvili G; Dores GM; Srour SA; Chaturvedi AK; Huycke MM; Devesa SS
Cancer; 2013 Jun; 119(12):2291-9. PubMed ID: 23580435
[TBL] [Abstract][Full Text] [Related]
15. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data.
Joura EA; Garland SM; Paavonen J; Ferris DG; Perez G; Ault KA; Huh WK; Sings HL; James MK; Haupt RM;
BMJ; 2012 Mar; 344():e1401. PubMed ID: 22454089
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus-related content in state and tribal comprehensive cancer control plans.
Steele CB; Thomas CN; Richardson LC
J Womens Health (Larchmt); 2008; 17(1):5-10. PubMed ID: 18240976
[TBL] [Abstract][Full Text] [Related]
17. From the monovalent to the nine-valent HPV vaccine.
Pils S; Joura EA
Clin Microbiol Infect; 2015 Sep; 21(9):827-33. PubMed ID: 25980355
[TBL] [Abstract][Full Text] [Related]
18. The incidence of genital warts in Australian women prior to the national vaccination program.
Brotherton JM; Heywood A; Heley S
Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
[TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus-Associated Cancers - United States, 2008-2012.
Viens LJ; Henley SJ; Watson M; Markowitz LE; Thomas CC; Thompson TD; Razzaghi H; Saraiya M
MMWR Morb Mortal Wkly Rep; 2016 Jul; 65(26):661-6. PubMed ID: 27387669
[TBL] [Abstract][Full Text] [Related]
20. [AN HPV-ASSOCIATED DISEASES AND CERVICAL CANCER AND PROPHYLACTIC HUMAN PAPILLOMAVIRUS (HPV) VACCINES].
Malinova M
Akush Ginekol (Sofiia); 2015; 54 Suppl 1():25-31. PubMed ID: 26137767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]